Over the past year, Fresenius Medical Care shares have declined by over 25%, despite 38% growth in 2025 adjusted earnings per share and a roughly stable profit outlook for 2026 from management.
Diversified by geography and business mix, Fresenius should be able to benefit from ongoing growth in treating ESRD patients worldwide in the long run.
With virtually all of its US service profits coming from commercial insurance, Fresenius' profits could contract in some negative policy scenarios.
|
Metric
|
FMS
|
DVA
|
HCA
|
|---|---|---|---|
Price/Earnings (Normalized) | 9.06 | 17.79 | 13.37 |
Price/Book Value | 0.82 | — | — |
Price/Sales | 0.59 | 1.10 | 1.19 |
Price/Cash Flow | 4.16 | 6.83 | 7.38 |
|
Metric
|
FMS
|
DVA
|
HCA
|
|---|---|---|---|
Quick Ratio | 0.79 | 1.28 | 0.64 |
Current Ratio | 1.20 | 1.42 | 0.83 |
Interest Coverage | 4.66 | 3.38 | 5.29 |
|
Metric
|
FMS
|
DVA
|
HCA
|
|---|---|---|---|
Return on Assets (Normalized) | 4.14% | 7.49% | 13.39% |
Return on Equity (Normalized) | 9.71% | — | — |
Return on Invested Capital (Normalized) | 6.14% | 12.48% | 21.68% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| HCA Healthcare Inc
HCA
| Vqtzzfwy | Nvbkt | $86B | |||
| Fresenius SE & Co KGaA ADR
FSNUY
| — | Xzlgjy | $25B | |||
| IHH Healthcare Bhd
IHHHF
| — | Krhkdm | $19B | |||
| Tenet Healthcare Corp
THC
| Lzfxzzd | Rzmxh | $15B | |||
| DaVita Inc
DVA
| Nyjdjtqt | Xbcjn | $13B | |||
| Fresenius Medical Care AG
FMCQF
| — | Hhsvddr | $12B | |||
| Encompass Health Corp
EHC
| — | Gygyqj | $10B | |||
| Universal Health Services Inc Class B
UHS
| Tqbpfpry | Gvnsbcw | $9B | |||
| Genesis Healthcare Inc Class A
GENNQ
| Dvhkn | Ffpx | $3,666 |
/author-service-images-prod-us-east-1.publishing.aws.arc.pub/morningstar/27df33e4-c5eb-4dc8-805e-babc7c688b65.jpg)
United States